|
AKIRIN2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.75270000419326E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.761950E-03 |
| Normal-vs-Stage2 |
1.296060E-02 |
| Normal-vs-Stage3 |
1.744030E-03 |
| Normal-vs-Stage4 |
8.160400E-02 |
| Stage1-vs-Stage2 |
1.270810E-01 |
| Stage1-vs-Stage3 |
2.329800E-02 |
| Stage1-vs-Stage4 |
2.353400E-01 |
| Stage2-vs-Stage3 |
9.973800E-01 |
| Stage2-vs-Stage4 |
7.837600E-01 |
| Stage3-vs-Stage4 |
7.592200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.2493000001168E-07 |
| Normal-vs-AfricanAmerican |
1.120530E-03 |
| Normal-vs-Asian |
4.767000E-01 |
| Caucasian-vs-AfricanAmerican |
2.495800E-01 |
| Caucasian-vs-Asian |
7.283400E-01 |
| AfricanAmerican-vs-Asian |
9.614800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59910000002905E-06 |
| Normal-vs-Female |
5.79349999999534E-05 |
| Male-vs-Female |
1.068250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.920400E-03 |
| Normal-vs-Extreme_Weight |
2.297900E-03 |
| Normal-vs-Obese |
3.042600E-04 |
| Normal-vs-Extreme_Obese |
1.523580E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.285990E-01 |
| Normal_Weight-vs-Obese |
9.163400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.170400E-01 |
| Extreme_Weight-vs-Obese |
6.421700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.612800E-01 |
| Obese-vs-Extreme_Obese |
9.556000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.410130E-02 |
| Normal-vs-Age(41-60Yrs) |
4.83460000000324E-06 |
| Normal-vs-Age(61-80Yrs) |
5.80889999999279E-05 |
| Normal-vs-Age(81-100Yrs) |
5.177800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.572200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.803000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.141800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.225200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.117600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.145400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.25730000142011E-08 |
| Normal-VS-Type2 PRCC |
5.190400E-02 |
| Normal-VS-KIRP CIMP |
5.163800E-03 |
| Normal-VS-Unclassified PRCC |
1.176770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.080500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.971500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.594200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.166270E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.661000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.223610E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.300000E-02 |
| Normal-vs-N1 |
4.559900E-04 |
| Normal-vs-N2 |
7.600800E-01 |
| N0-vs-N1 |
6.881900E-03 |
| N0-vs-N2 |
6.978000E-01 |
| N1-vs-N2 |
1.735650E-01 |
|
|
